MedTrace Logo

Evaluation of a Nasal Allergen Challenge Procedure Using Dust Mite Extract

NCT00927329 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2017-05-05

No results posted yet for this study

Summary

The purpose of this study is to serve as a pilot safety study for nasal allergen challenges.

Conditions

  • Dermatophagoides Farinae Allergy
  • Asthma
  • Healthy

Interventions

BIOLOGICAL

dust mite inhalation

Nasal allergen challenge will be provided in a graded dose fashion of 0 AU, 100 AU, 500 AU, and 1000 AU separated by 20 minutes.

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • David Peden, MD · University of North Carolina, Chapel Hill

  • Michelle Hernandez, MD · University of North Carolina, Chapel Hill

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2017-04-30
Completion
2017-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00927329 on ClinicalTrials.gov